FDA approves Lyumjev® (insulin lispro-aabc injection) 100 units/mL for use in insulin pumps

U.S. approval of pump use for Lilly's novel insulin is latest development designed to help people with diabetes manage blood sugar levels INDIANAPOLIS , Aug. 16, 2021 /PRNewswire/ -- The U.S.   Food and Drug Administration (FDA) has approved an expanded label for  Eli Lilly and Company's (NYSE: